Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Retained Earnings (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Retained Earnings data on record, last reported at -$330.6 million in Q4 2025.

  • For Q4 2025, Retained Earnings fell 18.26% year-over-year to -$330.6 million; the TTM value through Dec 2025 reached -$330.6 million, down 18.26%, while the annual FY2025 figure was -$330.6 million, 18.26% down from the prior year.
  • Retained Earnings reached -$330.6 million in Q4 2025 per TLSI's latest filing, down from -$321.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$11.5 million in Q2 2022 and bottomed at -$330.6 million in Q4 2025.
  • Average Retained Earnings over 4 years is -$189.4 million, with a median of -$255.6 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: grew 0.19% in 2023, then crashed 1788.1% in 2024.
  • A 4-year view of Retained Earnings shows it stood at -$186.4 million in 2022, then tumbled by 33.88% to -$249.5 million in 2023, then dropped by 12.04% to -$279.5 million in 2024, then dropped by 18.26% to -$330.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$330.6 million in Q4 2025, -$321.0 million in Q3 2025, and -$298.2 million in Q2 2025.